Outcomes of lower urinary and bowel function in meningomyelocele patients with augmentation enterocystoplasty

Spinal Cord

Volumn 46, Issue 6, 2008, Pages 432-437

  Mitsui, T ^a   Tanaka, H ^a   Moriya, K ^a   Matsuda, M ^a   Nonomura, K ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Augmentation ileocystoplasty; Bowel function; Lower urinary tract function; Meningomyelocele; Quality of life

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUGMENTATION ENTEROCYSTOPLASTY; AUGMENTATION ILEOCYSTOPLASTY; BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER RECONSTRUCTION; CECOSTOMY; CLINICAL ARTICLE; FECES INCONTINENCE; FEMALE; HUMAN; INTESTINE FUNCTION; INTESTINE SURGERY; MALE; MENINGOMYELOCELE; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SURGICAL TECHNIQUE; URETER; URETHROPLASTY; URINARY DYSFUNCTION; URINARY TRACT FUNCTION; URINE INCONTINENCE; URODYNAMICS; VESICOURETERAL REFLUX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MENINGOMYELOCELE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; URINARY BLADDER; URINARY RESERVOIRS, CONTINENT; URODYNAMICS; UROLOGIC SURGICAL PROCEDURES;

EID: 44849134455     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3102164     Document Type: Article

References (22)

1. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972; 107: 458-461.
2. Altaweel W, Jednack R, Bilodeau C, Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 2006; 175: 1102-1105.
3. Riccabona M, Koen M, Schindler M, Goedele B, Pycha A, Lusuardi L et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 2004; 171: 845-848; discussion 848.
4. Quek ML, Ginsberg DA. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol 2003; 169: 195-198.
5. Blaivas JG, Weiss JP, Desai P, Flisser AJ, Stember DS, Stahl PJ. Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. J Urol 2005; 173: 1631-1634.
6. Venn SN, Mundy AR. Long-term results of augmentation cystoplasty. Eur Urol 1998; 34 (Suppl 1): 40-42.
7. Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P. Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 2000; 38: 490-494.
8. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178.
9. Frohneberg D, Bachor R, Egghart G, Miller K, Hautmann R. Ileal neobladder. Principles of function and continence. Eur Urol 1989; 16: 241-249.
10. Goodwin WE, Winter CC, Barker WF. Cup-patch technique of ileocystoplasty for bladder enlargement or partial substitution. Surg Gynecol Obstet 1959; 108: 240-244.
11. Weinberg AC, Boyd SD, Lieskovsky G, Ahlering TE, Skinner DG. The hemi-Kock augmentation ileocystoplasty: a low pressure anti-refluxing system. J Urol 1988; 140: 1380-1384.
12. Malone PS, Ransley PG, Kiely EM. Preliminary report: the antegrade continence enema. Lancet 1990; 336: 1217-1218.
13. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981; 126: 205-209.
14. Kobayashi S, Shinno Y, Kakizaki H, Matsumura K, Koyanagi T. Relevance of detrusor hyperreflexia, vesical compliance and urethral pressure to the occurrence of vesicoureteral reflux in myelodysplastic patients. J Urol 1992; 147: 413-415.
15. Bauer SB, Hallett M, Khoshbin S, Lebowitz RL, Winston KR, Gibson S et al. Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 1984; 252: 650-652.
16. Lopez Pereira P, Martinez Urrutia MJ, Lobato Romera R, Jaureguizar E. Should we treat vesicoureteral reflux in patients who simultaneously undergo bladder augmentation for neuropathic bladder? J Urol 2001; 165: 2259-2261.
17. Somani BK, Kumar V, Wong S, Pickard R, Ramsay C, Nabi G et al. Bowel dysfunction after transposition of intestinal segments into the urinary tract: 8-year prospective cohort study. J Urol 2007; 177: 1793-1798.
18. N'Dow J, Leung HY, Marshall C, Neal DE. Bowel dysfunction after bladder reconstruction. J Urol 1998; 159: 1470-1474;discussion 1474-1475.
19. Singh G, Thomas DG. Bowel problems after enterocystoplasty. Br J Urol 1997; 79: 328-332.
20. Thorstenson A, Jacobsson H, Onelov E, Holst JJ, Hellstrom PM, Kinn AC. Gastrointestinal function and metabolic control after construction of an orthotopic ileal neobladder in bladder cancer. Scand J Urol Nephrol 2007; 41: 14-19.
21. Lefevre JH, Parc Y, Giraudo G, Bell S, Parc R, Tiret E. Outcome of antegrade continence enema procedures for faecal incontinence in adults. Br J Surg 2006; 93: 1265-1269.
22. Yerkes EB, Cain MP, King S, Brei T, Kaefer M, Casale AJ et al. The Malone antegrade continence enema procedure: quality of life and family perspective. J Urol 2003; 169: 320-323.